Optimal Pharmacological Therapy In Implantable Defibrillator Patients (OPTIC)

Connolly, Stuart, M.D.

Status and phase: Completed; Phase 4

Conditions: Ventricular Tachycardia

Treatments: Drug: amiodarone beta blocker sotalol

Study type: Interventional

Funder types: Industry

Identifiers

NCT00257959

1

Details and patient eligibility

About

This is an open parallel design randomized trial of amiodarone plus a beta blocker vs a beta blocker alone vs sotalol for the prevention of ICD shocks in patients receiving an ICD for spontaneous or inducible ventricular tachycardia or fibrillation

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: spontaneous or inducible ventricular tachycardia or fibrillation -

Exclusion Criteria:

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)